Australia's most trusted
source of pharma news
Thursday, 21 November 2024
Posted 18 November 2024 PM
Despite continued warnings from the TGA, counterfeits of ivermectin, commonly known as MSD's Stromectol, continue to be imported into Australia with the regulator actively working with the Australian Border Force (ABF) to help stop further shipments.
The TGA warned of the importation of ivermectin and the risk associated with counterfeit therapeutic goods in December 2021, and again in March 2022.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.